Similar articles

• Erratum: Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor-Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321).

  Sharman JP, Munir T, Grosicki S, Roeker LE, Burke JM, Chen CI, Grzasko N, Follows G, Mátrai Z, Sanna A, Qiu L, Feng R, Hua VM, Jurczak W, Ritgen M, Yi S, Bosch F, Coombs CC, Bao K, Patel V, Liu B, Compte L, Guntur A, Wang DY, Hill M, Leow CC, Ghia P, Barr PM. Sharman JP, et al. J Clin Oncol. 2025 Sep;43(25):2841. doi: 10.1200/JCO-25-01700. Epub 2025 Jul 29. J Clin Oncol. 2025. PMID: 40729625 No abstract available.
• Pirtobrutinib versus venetoclax in covalent Bruton tyrosine kinase inhibitor-pretreated chronic lymphocytic leukemia: a matching-adjusted indirect comparison.

  Al-Sawaf O, Jen MH, Hess LM, Zhang J, Goebel B, Pagel JM, Abhyankar S, Davids MS, Eyre TA. Al-Sawaf O, et al. Haematologica. 2024 Jun 1;109(6):1866-1873. doi: 10.3324/haematol.2023.284150. Haematologica. 2024. PMID: 38031799 Free PMC article. Clinical Trial.
• Pirtobrutinib in Chinese patients with relapsed or refractory B-cell malignancies: A single-arm, open-label, phase 2, multicenter trial.

  Liu Y, Lin N, Yi S, Huang H, Guo Y, Zhang Q, Yang H, Zhang H, Zhang L, Feng R, Qian Y, Zhu J, Song Y, Zhu J. Liu Y, et al. Int J Cancer. 2025 Jun 1;156(11):2158-2168. doi: 10.1002/ijc.35339. Epub 2025 Feb 28. Int J Cancer. 2025. PMID: 40018797 Free PMC article. Clinical Trial.
• Indirect Treatment Comparisons of Ibrutinib Versus Physician's Choice and Idelalisib Plus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia.

  Sorensen S, Wildgust M, Sengupta N, Trambitas C, Diels J, van Sanden S, Xu Y, Dorman E. Sorensen S, et al. Clin Ther. 2017 Jan;39(1):178-189.e5. doi: 10.1016/j.clinthera.2016.12.001. Epub 2017 Jan 3. Clin Ther. 2017. PMID: 28062113
• Beyond BCL2 (B cell lymphoma) and BTK (Bruton tyrosine kinase) inhibitors: novel agents and resistance mechanisms for chronic lymphocytic leukemia.

  Hays P. Hays P. Discov Oncol. 2025 Jun 14;16(1):1100. doi: 10.1007/s12672-025-02947-9. Discov Oncol. 2025. PMID: 40515863 Free PMC article. Review.